CHU Montpellier - Hôpital Lapeyronie

Montpellier 34295

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Severe Hypertriglyceridemia

Studies at this site

• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed